Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Plasma (single spun) (1)
• Saliva (1)
• Serum (3)
• Solid tissue (non viable) (1)
• Stool (1)
• Urine (random) (3)

Microscopic Assessment

• Affected (2)
• Not applicable (3)

Storage Temperature

• RT (1)
• -85°C to -60°C (4)
• Liquid nitrogen (1)

Preservation Type

• N/A (2)

Associated Data

• Biomarker datasets (1)
• Clinical records (4)
• Followup records (3)
• Freezer temperature logs (2)
• Microbiological results (1)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (1)
• Pre-analytical data (3)
• Quality indicators (1)
• Survey data (2)
• Treatment records (3)

Timeframe

• Immediate (2)
• 0 - 3 months (4)
• 3 - 6 months (2)
• > 6 months (4)

Participant Count

• 11 - 100 (2)
• 101 - 500 (2)
• 1001 - 3000 (1)

Sex

• Both sexes (4)

Age Range

• Adult (> 40 years) (4)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Digital imaging (1)
• Immunohistochemistry - staining (1)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (3)

Collection Type

• Cohort (1)
• Cross-sectional (1)
• Disease specific (1)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (3)
• No Export restriction (4)
• No Genetic analysis restriction (3)
• No Human genetic analysis restriction (3)
• No restrictions (0)
• No Project specific restriction (4)
• No Scope of use restriction (2)

Collection Status

• Completed (1)
• In progress (3)

Access Condition

• Open to applicants (3)
• Open in response to specific calls (1)
• Open only through collaboration (1)

Country

• Germany (1)
• Peru (1)
• Spain (1)
• Switzerland (1)

County